We passionately join cancer patients in their fight for effective, safe, non-toxic cancer treatments that increase quality of life and survival. As a weapon, we are developing viral immunotherapy which has the potential to drastically improve the clinical treatment of solid tumours and their metastases.
Our innovations will overcome the barriers to widespread use of viral immunotherapy
Funded by Deep Science Ventures, its partners and CRUK, Stratosvir has assembled significant expertise in virology, immunology, oncology and molecular engineering to guide its mission.
We use cookies to analyze website traffic and optimize your website experience and not for advertising. By accepting our use of cookies, your data will be aggregated with all other user data. We value transparency and a link to our privacy policy can be found on our Contact Us page.